MUMBAI Shares of Ranbaxy Laboratories(RANB.NS) fell as much as 2.7 percent after the drug maker said on Tuesday it has suspended shipments of pharmaceutical ingredients produced at its Toansa and Dewas plants.
"This voluntary decision was taken as a precautionary measure and out of abundant caution to better allow the company to assess and review the processes and controls. The company will resume shipments after reassuring them about the processes and controls at these facilities," Ranbaxy said in an exchange filing.
Ranbaxy shares were trading up 0.7 percent at 11.46 a.m.
(Reporting by Abhishek Vishnoi; Editing by Subhranshu Sahu)
Trending On Reuters
- Lackluster U.S., China sales drag on Ford Motor profit, shares tumble
- Fall in Volkswagen brand profit shows lasting effects of scandal
- Shell misses expectations as earnings plunge on oil, BG costs
- SoftBank sees sharp recovery for Sprint, flags much investment for ARM
- Facebook shares hit record high as it beats estimates again